Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2025-12-28 @ 11:48 PM
Study NCT ID:
NCT06134232
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2023-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor:
Dendreon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2031-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-18
First Submit QC Date:
None
Study First Post Date:
2023-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-20
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED